These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9399760)

  • 41. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute delta hepatitis: serological diagnosis with particular reference to hepatitis delta virus RNA.
    Gupta S; Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Am J Gastroenterol; 1991 Sep; 86(9):1227-31. PubMed ID: 1882801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
    Niro GA; Ciancio A; Tillman HL; Lagget M; Olivero A; Perri F; Fontana R; Little N; Campbell F; Smedile A; Manns MP; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2005 Aug; 22(3):227-32. PubMed ID: 16091060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HDV seroprevalence in HBsAg positive patients.
    Abbasi A; Bhutto AR; Butt N; Mahmood K
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):624-7. PubMed ID: 25233963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
    Zachou K; Yurdaydin C; Drebber U; Dalekos GN; Erhardt A; Cakaloglu Y; Degertekin H; Gurel S; Zeuzem S; Bozkaya H; Schlaphoff V; Dienes HP; Bock TC; Manns MP; Wedemeyer H;
    Liver Int; 2010 Mar; 30(3):430-7. PubMed ID: 19840253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis delta virus infection: open issues.
    Niro GA; Gioffreda D; Fontana R
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S19-24. PubMed ID: 21195367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.
    Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M
    J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
    Saravanan S; Velu V; Kumarasamy N; Shankar EM; Nandakumar S; Murugavel KG; Balakrishnan P; Solomon S; Thyagarajan SP
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):793-6. PubMed ID: 18556033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection.
    Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Prog Clin Biol Res; 1991; 364():207-10. PubMed ID: 2020697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.
    Raimondo G; Brunetto MR; Pontisso P; Smedile A; Maina AM; Saitta C; Squadrito G; Tono N;
    Hepatology; 2006 Jan; 43(1):100-7. PubMed ID: 16323213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the risk of hepatitis delta virus (HDV) infection in a population of hemodialyzed patients: significance of the determination of anti-delta antibodies in the blood].
    Calcara G; Rapisarda F; Rapisarda C; Brischetto R; Fatuzzo P; Seminara G; Vasta E; Motta M
    Arch Ital Urol Nefrol Androl; 1989 Sep; 61(3):229-33. PubMed ID: 2529638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HDAg-L variants in covert hepatitis D and HBV occult infection among Amerindians of Argentina: new insights.
    Delfino CM; Eirin ME; Berini C; Malan R; Gentile E; Castillo A; Pedrozo W; Krupp R; Blejer J; Oubiña JR; Mathet VL; Biglione MM
    J Clin Virol; 2012 Jul; 54(3):223-8. PubMed ID: 22608280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virus.
    Machado IV; Deibis L; Zabaleta M; Toro FI; Marino V; Ramirez JL; DePerez FE; Bianco NE
    Prog Clin Biol Res; 1991; 364():105-13. PubMed ID: 2020687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
    Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
    J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
    Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
    Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis delta virus infection in mongolia: analyses of geographic distribution, risk factors, and disease severity.
    Davaalkham D; Ojima T; Uehara R; Watanabe M; Oki I; Nymadawa P; Takahashi M; Okamoto H; Nakamura Y
    Am J Trop Med Hyg; 2006 Aug; 75(2):365-9. PubMed ID: 16896150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatitis delta virus infection: an immunohistochemical study].
    Preisegger KH; Denk H
    Wien Klin Wochenschr; 1989 Sep; 101(16):544-7. PubMed ID: 2678760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.